Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions

Chiho Ono, Hironori Kikkawa, Akiyuki Suzuki, Misaki Suzuki, Yuichi Yamamoto, Katsuomi Ichikawa, Masato Fukae, Ichiro Ieiri

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Drug transporters, together with drug metabolic enzymes, are major determinants of drug disposition and are known to alter the response to many commonly used drugs. Substantial frequency differences for known variants exist across geographic regions for certain drug transporters. To deliver efficacious medicine with the right dose for each patient, it is important to understand the contribution of genetic variants for drug transporters. Recently, mutual pharmacokinetic data usage among Asian regions, which are thought to be relatively similar in their own genetic background, is expected to accelerate new drug applications and reduce developmental costs. Polymorphisms of drug transporters could be key factors to be considered in implementing multiethnic global clinical trials. This review addresses the current knowledge on genetic variations of major drug transporters affecting drug disposition, efficacy and toxicity, focusing on the east Asian populations, and provides insights into future directions for precision medicine and drug development in east Asia.

Original languageEnglish
Pages (from-to)1745-1764
Number of pages20
JournalPharmacogenomics
Volume14
Issue number14
DOIs
Publication statusPublished - Jan 1 2013

Fingerprint

Ethnic Groups
Pharmaceutical Preparations
Precision Medicine
Far East
Pharmacokinetics
Medicine
Clinical Trials
Costs and Cost Analysis

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this

Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions. / Ono, Chiho; Kikkawa, Hironori; Suzuki, Akiyuki; Suzuki, Misaki; Yamamoto, Yuichi; Ichikawa, Katsuomi; Fukae, Masato; Ieiri, Ichiro.

In: Pharmacogenomics, Vol. 14, No. 14, 01.01.2013, p. 1745-1764.

Research output: Contribution to journalReview article

Ono, C, Kikkawa, H, Suzuki, A, Suzuki, M, Yamamoto, Y, Ichikawa, K, Fukae, M & Ieiri, I 2013, 'Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions', Pharmacogenomics, vol. 14, no. 14, pp. 1745-1764. https://doi.org/10.2217/pgs.13.171
Ono, Chiho ; Kikkawa, Hironori ; Suzuki, Akiyuki ; Suzuki, Misaki ; Yamamoto, Yuichi ; Ichikawa, Katsuomi ; Fukae, Masato ; Ieiri, Ichiro. / Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions. In: Pharmacogenomics. 2013 ; Vol. 14, No. 14. pp. 1745-1764.
@article{94ddc435463f4c45b25b8ddecd7672a0,
title = "Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions",
abstract = "Drug transporters, together with drug metabolic enzymes, are major determinants of drug disposition and are known to alter the response to many commonly used drugs. Substantial frequency differences for known variants exist across geographic regions for certain drug transporters. To deliver efficacious medicine with the right dose for each patient, it is important to understand the contribution of genetic variants for drug transporters. Recently, mutual pharmacokinetic data usage among Asian regions, which are thought to be relatively similar in their own genetic background, is expected to accelerate new drug applications and reduce developmental costs. Polymorphisms of drug transporters could be key factors to be considered in implementing multiethnic global clinical trials. This review addresses the current knowledge on genetic variations of major drug transporters affecting drug disposition, efficacy and toxicity, focusing on the east Asian populations, and provides insights into future directions for precision medicine and drug development in east Asia.",
author = "Chiho Ono and Hironori Kikkawa and Akiyuki Suzuki and Misaki Suzuki and Yuichi Yamamoto and Katsuomi Ichikawa and Masato Fukae and Ichiro Ieiri",
year = "2013",
month = "1",
day = "1",
doi = "10.2217/pgs.13.171",
language = "English",
volume = "14",
pages = "1745--1764",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "14",

}

TY - JOUR

T1 - Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions

AU - Ono, Chiho

AU - Kikkawa, Hironori

AU - Suzuki, Akiyuki

AU - Suzuki, Misaki

AU - Yamamoto, Yuichi

AU - Ichikawa, Katsuomi

AU - Fukae, Masato

AU - Ieiri, Ichiro

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Drug transporters, together with drug metabolic enzymes, are major determinants of drug disposition and are known to alter the response to many commonly used drugs. Substantial frequency differences for known variants exist across geographic regions for certain drug transporters. To deliver efficacious medicine with the right dose for each patient, it is important to understand the contribution of genetic variants for drug transporters. Recently, mutual pharmacokinetic data usage among Asian regions, which are thought to be relatively similar in their own genetic background, is expected to accelerate new drug applications and reduce developmental costs. Polymorphisms of drug transporters could be key factors to be considered in implementing multiethnic global clinical trials. This review addresses the current knowledge on genetic variations of major drug transporters affecting drug disposition, efficacy and toxicity, focusing on the east Asian populations, and provides insights into future directions for precision medicine and drug development in east Asia.

AB - Drug transporters, together with drug metabolic enzymes, are major determinants of drug disposition and are known to alter the response to many commonly used drugs. Substantial frequency differences for known variants exist across geographic regions for certain drug transporters. To deliver efficacious medicine with the right dose for each patient, it is important to understand the contribution of genetic variants for drug transporters. Recently, mutual pharmacokinetic data usage among Asian regions, which are thought to be relatively similar in their own genetic background, is expected to accelerate new drug applications and reduce developmental costs. Polymorphisms of drug transporters could be key factors to be considered in implementing multiethnic global clinical trials. This review addresses the current knowledge on genetic variations of major drug transporters affecting drug disposition, efficacy and toxicity, focusing on the east Asian populations, and provides insights into future directions for precision medicine and drug development in east Asia.

UR - http://www.scopus.com/inward/record.url?scp=84897029728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897029728&partnerID=8YFLogxK

U2 - 10.2217/pgs.13.171

DO - 10.2217/pgs.13.171

M3 - Review article

C2 - 24192123

AN - SCOPUS:84897029728

VL - 14

SP - 1745

EP - 1764

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 14

ER -